Proxy Votes Now

Home › Funds › State Street › State Street SPDR S&P Health Care Equipment ETF

State Street SPDR S&P Health Care Equipment ETF (XHE) proxy voting record 2025-2026

Fund family: State Street · Filed by SPDR SERIES TRUST (CIK 1064642) · SEC series S000012330

Ticker: XHE (C000033546)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 413 with, 261 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with State Street as a whole

The same two figures as State Street’s manager page (773,265 ballot items across 134 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsState StreetItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)97.2%64889.7%592,191
Backed environmental and social shareholder proposals at US companiesn/a06.8%3,767

Where this fund voted differently from most State Street funds

Each ballot item this fund voted is set against the votes of the other State Street funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most State Street funds on all 665 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 99.6% of this fund’s 674 such votes could be given a sector; the other 3 (0.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care65524837.9%
Technology161275.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections466171
Say-on-Pay7029
Audit-related6736
Compensation3416
Corporate Governance218
Capital Structure121
Shareholder Rights and Defenses50
Extraordinary Transactions40

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Senseonics Holdings, Inc.September 29, 2025$6M10
Glaukos CorporationMay 28, 2026$6M44
Haemonetics CorporationJuly 24, 2025$5M114
AtriCure, Inc.May 18, 2026$4M135
Axogen, Inc.June 23, 2026$4M101
Edwards Lifesciences CorporationMay 7, 2026$3M124
DexCom, Inc.May 27, 2026$3M146
SI-BONE, Inc.June 4, 2026$3M43

Notable votes against management

MeetingCompanyProposalFundMgmt
May 28, 2026Glaukos CorporationElection of Directors: Denice M. TorresForAgainst
May 28, 2026Glaukos CorporationElection of Directors: Aimee S. WeisnerForAgainst
July 24, 2025Haemonetics CorporationElection of Directors: Charles J. DockendorffForAgainst
July 24, 2025Haemonetics CorporationElection of Directors: Mark W. KrollForAgainst
May 18, 2026AtriCure, Inc.Election of Directors: Deborah H. TelmanForAgainst
May 18, 2026AtriCure, Inc.Election of Directors: Robert S. WhiteForAgainst
June 23, 2026Axogen, Inc.To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026.ForAgainst
May 7, 2026Edwards Lifesciences CorporationElection of Directors: Kieran T. GallahueForAgainst
May 7, 2026Edwards Lifesciences CorporationElection of Directors: Nicholas J. ValerianiForAgainst
May 27, 2026DexCom, Inc.To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven AltmanForAgainst
May 27, 2026DexCom, Inc.To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas AugustinosForAgainst
June 4, 2026SI-BONE, Inc.Election of Directors: Jeffrey W. DunnForAgainst

Search this fund’s votes by company

679 ballot items at 68 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, State Street SPDR S&P Health Care Equipment ETF (XHE) voted at 68 shareholder meetings of 65 companies, on 679 ballot items in all. Where management made a recommendation, the fund followed it on 61.3% of the items and voted against it 261 times. Its most frequent area of disagreement was director elections (171 of its votes against management). It voted on 4 shareholder proposals. It voted FOR the board's own proposals more often than State Street's funds as a whole (97.2% against 89.7%). It voted the same way as most State Street funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of State Street’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.